Real-World Risankizumab Durability in High-Impact Psoriasis
HCPLive features Tina Bhutani, MD, MAS, on real-world risankizumab durability in high-impact psoriasis. The expert segment addresses what practice-grounded evidence means at the IL-23 prescription pa…